ArticleClinical rheumatology2026
Diagnostic delay in axial spondyloarthritis: demographic, socioeconomic, and healthcare barriers in the West Bank, Palestine.
Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDiagnostic delay in axial spondyloarthritis (axSpA) worsens outcomes and increases costs, yet evidence from low-resource settings is scarce. We aimed to quantify diagnostic delay in Palestine and test the hypothesis that referral pathway and socioeconomic factors are independently associated with prolonged delay.
methodWe conducted a cross-sectional study (July-November 2024) across rheumatology clinics in the West Bank. Adults fulfilling ASAS criteria for axSpA were enrolled via structured interviews. Diagnostic delay was defined as years from symptom onset to confirmed diagnosis. Non-parametric tests and Spearman correlations explored univariable associations. Prolonged delay was prespecified as ≥ 6 years and evaluated using multivariable logistic regression. Exploratory patient phenotypes were derived with Partitioning Around Medoids clustering.
resultsSeventy-nine patients were included (73% male; mean age 43.0 ± 12.2 years). Mean diagnostic delay was 6.37 ± 5.8 years (median 5). On univariable analyses, longer delay was associated with older age, lower education, low income, first contact with a general practitioner (GP), HLA-B27 negativity/unknown status, and absence of reduced spinal mobility. In multivariable models, GP first contact independently increased the odds of prolonged delay (OR 3.69, 95% CI 1.04-13.11; p = 0.044), while reduced spinal mobility was associated with shorter diagnostic delay (OR 0.16, 95% CI 0.03-0.70; p = 0.016). Clustering identified three diagnostic phenotypes; the longest delays occurred among patients with low education/income and GP-first referral.
conclusionsPalestinian patients with axSpA experience an average diagnostic delay exceeding six years, comparable to global estimates. Referral pathway is the principal modifiable barrier, whereas overt clinical signs (reduced spinal mobility) may trigger earlier recognition. Targeted GP education, streamlined referral protocols, and improved access to HLA-B27 testing are priorities for reducing delay in low-resource settings. Key Points • General practitioner referral was the strongest independent barrier to timely diagnosis, increasing the odds of prolonged delay more than threefold. • Reduced spinal mobility was associated with shorter delay, suggesting that overt physical findings facilitate earlier recognition and referral. • Socioeconomic disadvantage and HLA-B27 negativity were linked to longer delays in univariable analyses but lost significance after adjustment, indicating that healthcare system factors outweigh individual characteristics. • This first national study from Palestine underscores the need for GP education, accessible rheumatology pathways, and early use of HLA-B27 testing to shorten diagnostic delay in low-resource settings.
Indexed as
Identifiers
41779112What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.